PDL BioPharma, Inc. Treasury Stock, Retired, Par Value Method, Amount
PDL BioPharma, Inc. reported Treasury Stock, Retired, Par Value Method, Amount of $124.00 thousand for the 8-month period ending 2020-08-31, per its 10-K filed 2021-03-29.
Discontinued › Shareholders' Equity › Treasury Stock Transactions, Excluding Value of Shares Reissued
us-gaap:TreasuryStockRetiredParValueMethodAmount · last filed 2021-03-29
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for the quarter ending 2020-03-31 was $56.00K, a 58.52% decline year-over-year.
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for the quarter ending 2019-09-30 was $15.00K, a 150.00% increase year-over-year.
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for the quarter ending 2019-06-30 was $81.00K, a 12.50% increase year-over-year.
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for the quarter ending 2019-03-31 was $135.00K, a 1250.00% increase year-over-year.
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for fiscal 2019 was $263.00K, a 57.49% increase from fiscal 2018.
- PDL BioPharma, Inc. treasury stock, retired, par value method, amount for fiscal 2018 was $167.00K.
| Period end | Treasury Stock, Retired, Par Value Method, Amount 3 month | Treasury Stock, Retired, Par Value Method, Amount 6 month | Treasury Stock, Retired, Par Value Method, Amount 8 month | Treasury Stock, Retired, Par Value Method, Amount 9 month | Treasury Stock, Retired, Par Value Method, Amount 12 month | Treasury Stock, Retired, Par Value Method, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-08-31 | $124.00K 10-K · filed 2021-03-29 | |||||
| 2020-03-31 | $56.00K 10-Q · filed 2020-05-11 | |||||
| 2019-12-31 | $263.00K 10-K · filed 2021-03-29 | |||||
| 2019-09-30 | $15.00K 10-Q · filed 2019-11-06 | $96.00K derived: sum of 2 quarters · filed 2019-11-06 | $231.00K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2019-06-30 | $81.00K 10-Q · filed 2019-11-06 | $216.00K derived: sum of 2 quarters · filed 2020-05-11 | ||||
| 2019-03-31 | $135.00K 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | $167.00K 10-K · filed 2021-03-29 | |||||
| 2018-09-30 | $6.00K 10-Q · filed 2019-11-06 | $78.00K derived: sum of 2 quarters · filed 2019-11-06 | $88.00K derived: sum of 3 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $72.00K 10-Q · filed 2019-11-06 | $82.00K derived: sum of 2 quarters · filed 2019-11-06 | ||||
| 2018-03-31 | $10.00K 10-Q · filed 2019-11-06 | |||||
| 2017-12-31 | $133.00K 8-K · filed 2020-06-29 | -$133.00K 10-K · filed 2018-03-16 |